Skip to main content

BLUE BIOTECHNOLOGY

                       From Worldometer (new  COVID-19 deaths yesterday):

        DAY  USA  WORLD   Brazil    India    South Africa

June     9    1093     4732         1185        246       82
July    22     1205     7128         1293      1120     572
Aug    12     1504     6556        1242        835     130
Sept     9     1208      6222       1136       1168       82
Oct     21     1225      6849         571        703       85
Nov    25      2304    12025        620        518      118
Dec    30      3880    14748       1224       299      465
Jan     14       4142     15512        1151        189      712              
Feb      3       4005    14265       1209       107      398
Mar     2        1989      9490        1726       110      194
April   6          906     11787         4211       631       37
May    4         853     13667         3025     3786      59 
June   1         287    10637         2346      3205       95
 July   7          251      8440        1595        817       411
Aug    4          656    10120        1118         532      423 
Sept   1        1480    10470          703        505      235
          8        1700      9836          250        339     253
        14        1934      9001          709        281      300
        22       2228      9326          839        279      124
        29        2190      8859         643        309     108
Oct    5        1811       7495          686        285     103
          6        2102       8255         543        315       59

Summary:
  • Just when you thought the decline was occurring, we get this.  
  • Of course, the USA led with the most deaths yesterday, but #2 was Russia with 929, #3 Mexico with 790 and #4 Brazil with 543.
  • #5?  Texas with 364.

Said the New York Times this morning;

  • Economic growth has been disappointingly slow in the U.S., as has income growth for most families. According to many measures of well-being, the U.S. is faring worse than other high-income countries. Life expectancy here has risen less since 1980 than in Canada, Japan, Australia, Britain, France, Germany and dozens of other countries.

  • When Biden took office, the Democratic Party seemed united in its desire to reverse some of the sharp decline in high-end tax rates. Every Democrat in Congress — including Senator Joe Manchin of West Virginia — had voted against Donald Trump’s 2017 tax cut. And polls show that most voters support higher taxes on the rich. About 80 percent of Americans say they are bothered by wealthy people and companies not paying “their fair share” of taxes, according to the Pew Research Center.

  • House and Senate Democrats are shrinking Biden’s proposed tax increases, and the party still does not have a consensus on what a final bill should include. The tax plan will probably end up closer to a proposal from Manchin than Biden’s campaign platform.

Also from the NYT:

    • W.H.O. endorsed the first malaria vaccine, which could save the lives of many children in sub-Saharan Africa.
      • I might add that the vaccine to be used is known as RTS,S, requires four injections and has a relatively low efficacy of between 29-39%.  This version comes from GlaxoSmithKline with support from the Bill and Melinda Gates Foundation, and uses a recombinant platform.
      • There is a better one, known as R21/Matrix-M by the University of Oxford and partners, with a 77% effectiveness rate, but is still undergoing trials.
      • There is another candidate by Sanaria, which has been shown to have an efficacy of 80%, but needs to be stored in liquid nitrogen.
      • The RTS vaccine, when used with other treatments, does significantly reduce hospitalizations.
      • In 2019 there were 229 million malaria cases with 409,000 deaths.  In comparison, COVID-19, in 20 months or so has had 238 million cases and 4.9 million deaths.  In short, annually, malaria has more cases/year, but COVID-19 has almost 10 times the fatality rate.
      •  Children under the age of 5 years are the most vulnerable group.  Africa has 94% of all the malaria cases.
      • A sum close to $4 billion is annually spent to combat this disease.
      • By the way, that drug, hydrochloroquine, touted by Donald Trump, is used to treat malaria patients.
    • ALSO, A SCARE STORY OF A SERIAL KILLER:
      • MALARIA MAY GAVE KILLED HALF OF ALL THE PEOPLE THAT EVER LIVED!!!
      • MORE PEOPLE ARE TODAY INFECTED THAN ANY POINT IN HISTORY.
      • THE PARASITE (almost like an amoeba) RESPONSIBLE IS  Plasmodium falciparum, WHICH IS THE SERIAL KILLER.

Here is something you probably did not know:  

There are 200 types of mosquitos in the the continental United States.  12 of them can make you sick.  The Anopheles mosquito can be found in the USA.  See that big green area?

Today I will introduce you to the field of Blue Biotechnology, an element of the Blue Revolution, drawing from a special issue of Aquatic Microbial Resources for Sustainable Life on Earth.  This was a call for papers, with a submission deadline at the end of March 2022.


This special issue editors are:  Laurent Dufosse (above) of Reunion (France) and
 Ramesh Chatragadda (Goa, India).

Dear Colleagues,

Biotechnology is the exploitation or manipulation of living organisms, systems, and processes for the benefit of society, the environment, and industry. 

We all know the color code developed by Kafarski (2012) to differentiate the main areas of biotechnology: white (industrial), green (agricultural), blue (marine and fresh water), red (pharmaceutical), brown (desert biotechnology), and purple (patents and inventions), among others. More recently, insect biotechnology, an emerging field of applied entomology that covers the use of insects in drug discovery, food, and feed has been coded yellow.

Blue biotechnology seeks to explore and use marine and fresh-water biodiversity as, for example, a source of new products, bioprospecting the environment and using molecular biology and microbial ecology in fresh-water and marine organisms to obtain beneficial advances for humanity (Barcelos et al., 2018).

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

I'll close with a few photos sent to me by readers.  Some facts about pistacchios:

  • First cultivated in the region now known as Afghanistan and Iran, so prominent in the news today, and was grown in the Hanging Gardens of Babylon.
  • Tree lives up to 300 years and grows to 33 feet or so.  A mature one provides 50/000 seeds/two years.
  • Do you know why they were first dyed red or green?  To hide the shell stains.
  • Bet you didn't know that three-quarters of this nut comes from Iran and the USA, where it first arrived in 1854?
All these chemicals are found in your banana:

Lungs of a horse.

Finger from a gorilla:

-

Comments

Popular posts from this blog

A NEXT COVID SUBVARIANT?

By now most know that the Omicron BA.5 subvariant has become the dominant infectious agent, now accounting for more than 80% of all COVID-19 cases.  Very few are aware that a new one,   BA.4.6,  is sneaking in and steadily rising, now accounting for 13% of sequenced samples .  However, as BA.4.6 has emerged from BA.4, while there is uncertainty, the scientific sense is that the latest bivalent booster targeting BA.4 and BA.5 should also be effective for this next threat. One concern is that Evusheld--the only monoclonal antibody authorized for COVID prevention in immunocompromised individuals--is not effective against BA.4.6.  Here is a  reference  as to what this means.  A series of two injections is involved.  Evusheld was developed by British-Swedish company AstraZeneca, and is a t ixagevimab  co-packaged with  cilgavimab . More recently, Los Angeles County reported on  subvariant BA.2.75.2 . which Tony Fauci termed suspicious and troublesome.  This strain has also been spreading in

Part 3: OUR NEXT AROUND THE WORLD ODYSSEY

Before I get into my third, and final, part of this cruise series, let me start with some more newsworthy topics.  Thursday was my pandemic day for years.  Thus, every so often I return to bring you up to date on the latest developments.  All these  subvariants  derived from that Omicron variant, and each quickly became dominant, with slightly different symptoms.  One of these will shock you. There has been a significant decline in the lost of taste and smell.  From two-thirds of early patients to now only 10-20% show these symptoms. JN.1, now the dominant subvariant, results in mostly mild symptoms. However, once JN.1 infects some, there seem to be longer-lasting symptoms. Clearly, the latest booster helps prevent contracting Covid. A competing subvariant,  BA.2.86,  also known as Pirola , a month ago made a run, but JN.1 prevailed. No variant in particular, but research has shown that some of you will begin to  lose hair  for several months.  This is caused by stress more than anythi

HONOLULU TO SEATTLE

The story of the day is Hurricane Milton, now a Category 4 at 145 MPH, with a track that has moved further south and the eye projected to make landfall just south of Sarasota.  Good news for Tampa, which is 73 miles north.  Milton will crash into Florida as a Category 4, and is huge, so a lot of problems can still be expected in Tampa Bay with storm surge.  If the eye had crossed into the state just north of Tampa, the damage would have been catastrophic.  Milton is a fast-moving storm, currently at 17 MPH, so as bad as the rainfall will be over Florida, again, a blessing.  The eye will make landfall around 10PM EDT today, and will move into the Atlantic Ocean north of Palm Bay Thursday morning. My first trip to Seattle was in June of 1962 just after I graduated from Stanford University.  Caught a bus. Was called the  Century 21 Exposition .  Also the Seattle World's Fair.  10 million joined me on a six-month run.  My first. These are held every five years, and there have only been